Measles Research Today is a free monthly online journal that collates and summarizes the latest research about Measles, including details on german measles, symptoms, vaccine, treatment, rubella.

Volume 3 (2006), Issue 6 (June)

1. Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coverage.
   Pediatrics, 117(6): 1972-8. [Abstract] [Full-text]
2. A mouse model of persistent brain infection with recombinant Measles virus.
   J Gen Virol, 87: 2011-9. [Abstract] [Full-text]
3. Do childhood diseases affect NHL and HL risk? A case-control study from northern and southern Italy.
   Leuk Res, 30(8): 917-22. [Abstract] [Full-text]
4. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
   Vaccine, 24(25): 5381-9. [Abstract] [Full-text]
5. High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice.
   J Virol, 80(13): 6420-9. [Abstract] [Full-text]
6. Parental concerns and medical-seeking behavior after immunization.
   Am J Prev Med, 31(1): 32-5. [Abstract] [Full-text]
7. Angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms in children with subacute sclerosing panencephalitis.
   Am J Med Genet B Neuropsychiatr Genet, 141(5): 445-8. [Abstract] [Full-text]
8. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines.
   Microbes Infect. [Abstract] [Full-text]
9. Immunization status of children under 7 years in the Vikas Nagar area, North India.
   Child Care Health Dev, 32(4): 415-21. [Abstract] [Full-text]
10. Measles virus contact with T cells impedes cytoskeletal remodeling associated with spreading, polarization, and CD3 clustering.
    Traffic, 7(7): 849-58. [Abstract] [Full-text]
11. Measles viral load may reflect SSPE disease progression.
    Virol J, 3(1): 49. [Abstract] [Full-text]
12. Long term survival in subacute sclerosing panencephalitis: an enigma.
    Brain Dev, 28(7): 447-52. [Abstract] [Full-text]
13. Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics.
    Epidemiol Infect, 134(4): 845-9. [Abstract] [Full-text]
14. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Pediatr Infect Dis J, 25(7): 615-22. [Abstract] [Full-text]

© 2004-2010 Measles Research Today. All Rights Reserved.